Alzheimer's Imaging Consortium.

Alzheimers Dement

Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.

Published: December 2024

Background: Glutamate is the main excitatory neurotransmitter in the brain, acting through ionotropic and metabotropic receptors, such as the neuronal metabotropic glutamate receptor 5 (mGluR5). The radiotracer [11C]ABP688 binds allosterically to the mGluR5, providing a valuable tool to understand glutamatergic function. We have previously shown that neuronal [11C]ABP688 binding is influenced by astrocyte activation. Specifically, the activation of glutamate transport in astrocytes via glutamate-transporter-1 (GLT-1) results in an elevated [11C]ABP688 binding within the ventral anterior thalamus, but no changes in other regions. However, whether changes at the network level occur remains elusive. We evaluated Glutamatergic Brain Networks (GBNs) before and after activating astrocytes.

Method: Micro-PET acquisitions were performed in adult Sprague-Dawley rats (n = 5) at baseline and after a pharmacological challenge to activate astrocytes. Before the scan, rats received either saline (vehicle) or ceftriaxone (CEF, 200mg/kg), an antibiotic that induces GLT-1 activation. Then, [11C]ABP688 was administered i.v., followed by a 60-minute dynamic scan. The nondisplaceable binding potential (BPND) was estimated using the simplified reference tissue model, with the cerebellum as a reference region. [11C]ABP688 BPND was extracted for 12 volumes of interest. GBNs based on [11C]ABP688 regional BPND were assembled with a multiple sampling scheme in MATLAB (p-value < 0.05).

Result: Astrocyte activation induced GBN hyperconnectivity after astrocyte activation, with the strength of association between the cerebral hemispheres, such as in the frontal and parietal cortices (Figure 1, A-B). After GLT-1 activation, the connections were diffused, including regions that were not part of the network at baseline, such as the cerebellum. Graph measures show a significant increase in global efficiency, average degree, density, and average clustering coefficient (Figure 1, C-G). These measures indicate an increase in connections and network cohesiveness. The reduction in assortativity can be related to the new regions on the GBN after the challenge.

Conclusion: Our results show that GBNs assessed with [11C]ABP688 are sensitive to astrocyte activation. Alterations in glutamate levels, as observed in dysfunctions like glutamatergic excitotoxicity present in AD, could disrupt the cohesion of the glutamatergic network, leading to brain dysfunction.

Download full-text PDF

Source
http://dx.doi.org/10.1002/alz.094069DOI Listing

Publication Analysis

Top Keywords

astrocyte activation
16
[11c]abp688 binding
8
glt-1 activation
8
[11c]abp688
7
activation
7
alzheimer's imaging
4
imaging consortium
4
consortium background
4
glutamate
4
background glutamate
4

Similar Publications

Mitochondria and astrocyte reactivity: Key mechanism behind neuronal injury.

Neuroscience

January 2025

Biochemistry Department and Centro de Investigaciones Biomédicas (CEINBIO), Facultad de Medicina, Universidad de la República, Montevideo, Uruguay.

In this special issue to celebrate the 30th anniversary of the Uruguayan Society for Neuroscience (SNU), we find it pertinent to highlight that research on glial cells in Uruguay began almost alongside the history of SNU and contributed to the understanding of neuron-glia interactions within the international scientific community. Glial cells, particularly astrocytes, traditionally regarded as supportive components in the central nervous system (CNS), undergo notable morphological and functional alterations in response to neuronal damage, a phenomenon referred to as glial reactivity. Among the myriad functions of astrocytes, metabolic support holds significant relevance for neuronal function, given the high energy demand of the nervous system.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.

Background: N-acetyl-aspartate (NAA) and myo-inositol (mI) are neurometabolites reflecting neuronal viability and astrocyte activity, respectively. These can be quantified in vivo using proton magnetic resonance spectroscopy (1H-MRS). Previous studies have suggested that these metabolites could serve as biomarkers for Alzheimer's disease dementia (AD).

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Vaccinex, Inc., Rochester, NY, USA.

Background: The earliest recognized biomarker of AD is deposition of Aβ amyloid that leads to formation of plaques and may, over time, trigger or at least be followed by gliosis/neuroinflammation and neurofibrillary tangles, accompanied by neurodegenerative changes including neuronal and synaptic loss. We have previously reported that semaphorin 4D (SEMA4D), the major ligand of plexin B receptors expressed on astrocytes, is upregulated in diseased neurons during progression of AD and Huntington's disease (HD). Binding of SEMA4D to PLXNB receptors triggers astrocyte reactivity, leading to loss of neuroprotective homeostatic functions, including downregulation of glutamate and glucose transporters (doi:10.

View Article and Find Full Text PDF

Background: Alzheimer's disease is a devastating neurodegenerative disorder with a complex pathogenesis. One main pathological feature utilised in diagnosis is neurodegeneration or neuronal injury, which is reflected in reductions in cerebral glucose metabolism measured by [18F]Fluorodeoxyglucose ([18F]FDG) positron emission tomography (PET). Here we evaluated the involvement of glial reactivity measured with magnetic resonance spectroscopy (MRS) and cerebral blood flow measured with arterial spin labelling (ASL) on [18F]FDG PET as a measure of cerebral glucose metabolism.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

University of Kentucky College of Medicine, Sanders-Brown Center on Aging, Lexington, KY, USA.

Background: Alzheimer's disease (AD) and vascular cognitive impairment and dementia (VCID) are the predominant types of dementia in older adults, associated with memory loss and cognitive deficits. White matter hyperintensities (WMH) are linked to both AD and VCID. Astrocytes play a crucial role in WM integrity, encompassing functions like neuroinflammation, oxidative stress, and Aβ clearance.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!